ADVANCED MEDICAL SOLUTIONS GROUP PLC — AGM Information 2016

May 3, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1316X

Advanced Medical Solutions Grp PLC

03 May 2016

3 May 2016

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Annual Report and Accounts for the year ended

31 December 2015 and Notice of AGM

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, is pleased to announce that in accordance with AIM Rules 20 and 26, the Annual Report and Financial Statements for the year ended 31 December 2015 were posted to shareholders today and are available on the Investor Relations section of the Company's website http://www.admedsol.com/Investor-Relations 

The notice of meeting convening the Annual General Meeting of the Company, which will be held on 2 June 2016 at 11 a.m. at the offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP, was also posted to shareholders today and is available on the Company's website.

-     Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director
Consilium Strategic Communications	Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys
Investec Bank PLC (NOMAD & Broker)	Tel: +44 (0) 20 7597 5970
Gary Clarence / Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 510 employees.  For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUOONRNSAVRAR